Implant Sciences’ QS-B220 explosive detector qualifies ECAC’s evaluation process

The European Civil Aviation Conference’s (ECAC) Common Evaluation Process of Security Equipment (CEP) has approved Implant Sciences’ (IMSC) QS-B220 explosives trace detector (ETD) for deployment in airport checkpoint screening of passengers and baggage.

The latest move makes QS-B220 the first ETD to qualify the European agency’s tough laboratory testing protocol.

Implant Sciences Global Sales & Marketing vice-president Dr Darryl Jones said: "The 44 EU member nations covered by the ECAC approval represent an enormous opportunity for Implant Sciences.

"Procurements across the region have been delayed while this standard was established and implemented.

Recently added to the US Transportation Security Administration’s (TSA) qualified products list (QPL) in the US, the QS-B220 integrates Ion mobility spectrometry (IMS) to quickly detect and identify trace amounts of a range of military, commercial, and domestic explosives.

Implant Sciences president and CEO Glenn Bolduc said: "Our company has achieved an unprecedented number of ETD approvals in a very short period of time, making the QS-B220 one of the most widely approved products in the world.

"We have been gearing up in anticipation of these approvals, and we believe that we are ready to execute on these important opportunities."

The new explosives trace detectors feature a radioactive material-free design; push-button maintenance and diagnostics; and an inCal internal automatic calibration system.